The platform isn't theoretical. It's running today for a regulated clinical client. Here's the engagement, the architecture, and what your tenant inherits from that work.
Eternal Hair & Esthetics is a multi-vertical clinical operation under FDA 503A compounding regulations — three verticals (hair, esthetics, longevity), named physicians (Dr. Tawfik, Dr. Elder, Dr. Kirten), Allergan Top 250 credential, two physical clinics. Every piece of patient-facing content runs through the OVYN platform. Today.
Honest framing for the pitch: Demo Therapeutics would be our first pharma deployment. The platform mechanics are proven; the brand brain configuration is built fresh during the 6-week onboarding. We've architected for pharma from day one — that's why the FDA/OPDP rule library, Veeva integration spec, and ISI handling are all designed in even though they're not in production yet.
The numbers below are real, queried from the live Eternal database on April 28, 2026. Not benchmarks, not forecasts — actual platform throughput. Eternal is a multi-vertical regulated clinical operation under FDA 503A; it's not biotech DTC, but the platform mechanics are identical to what your tenant would inherit.
Eternal is a small operation — the platform is sized to fit it, not to fake scale. What matters is the rail mechanics work. 97.5% pass rate on ad variants and a 132-fact canon means the architecture is real, not slideware. Your pilot will show measurable cycle-time improvement on your specific brief — which is more defensible than any number above.